Antibacterial activity of novel naphthoquiones derivatives

Genes and Genomics

Volumn 31, Issue 6, 2009, Pages 429-434

  Chung, Yongseog ^a   Quan, Ren Shu ^b   Chang, Hyeon Mo ^a   Kwon, Soo Han ^a   Kim, Soon Ja ^b   Im, Young Sam ^b   Shin, Kyeong Seob ^b   Park, Kyung Do ^c   Lee, Hak Kyo ^c   Choi, Joong Kook ^b  

^a Chungbuk National University   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

^c Hankyong National University   (South Korea)

Author keywords

Disc assay; Naphthoquinone; Staphylococcus aureus; Topoisomerase II

Indexed keywords

STAPHYLOCOCCUS AUREUS;

EID: 75749147028     PISSN: 19769571     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03191856     Document Type: Article

References (20)

1. Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover F and Gaynes R (1997) Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin. Infect. Dis. 24:211-215.
2. Bhavnani SM, Drake JA, Forrest A, Deinhart JA, Jones RN, Biedenbach DJ and Ballow CH (2000) A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and-susceptible enterococcal bacteremia. Diagn. Microbiol. Infect. Dis. 36:145-158.
3. Chambers HF and Deleo FR (2009) Waves of resistance: Staphylococcus aureus in the antibioticera. Nat. Rev. Microbiol. 7:629-641.
4. Chopra I (1992) Efflux-based antibiotic resistance mechanisms: the evidence for increasin prevalence. J. Antimicrob. Chemother. 30:737-739.
5. Chung Y, Shin YK, Zhan CG, Lee S and Cho H (2004) Synthesis and evaluation of antitumor activity of 2-and 6-[(1,3-benzothiazol-2-yl) aminomethyl]-5, 8-dimethoxy-1,4-naphthoquinone derivatives. Arch. Pharm. Res. 27:893-900.
6. Deurenberg RH and Stobberingh EE (2008) The evolution of Staphylococcus aureus. Infect. Genet. Evol. 8:747-763.
7. Didry N, Pinkas M and Dubreuil L (1986) Antibacterial activity of naphthoquinones of plant origin. Ann. Pharm. Fr. 44:73-78.
8. Foye MO (1995) Cancer chemotherapeutic agents. Washington DC, 203 pp.
9. Gutierrez PL (1989) Mechanism (s) of bioreductive activation. The example of diaziquone (AZQ). Free. Radic. Biol. Med. 6:405-445.
10. Kim ES, Song JS, Lee HJ, Choe PG, Park KH, Cho JH, Park WB, Kim SH, Bang JH, Kim DM, Park KU, Shin S, Lee MS, Choi HJ, Kim NJ, Kim EC, Oh MD, Kim HB and Choe KW (2007) A survey of community associated methicillin-resistant Staphylococcus aureus in Korea. J. Antimicrob. Chemother. 60:1108-1114.
11. Kresken M and Wiedemann B (1988) Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin. Antimicrob. Agents. Chemother. 32:1285-1288.
12. Leopold WR, Shillis JL, Mertus AE, Nelson JM, Roberts BJ and Jackson RC (1984) Anticancer activity of the structurally novel antibiotic Cl-920 and its analogues. Cancer. Res. 44:1928-1932.
13. Papageorgiou VP, Assimopoulou AN, Couladouros EA, Hepworth D and Nicolaou KC (1999) The chemistry and biology of alkannin, shikonin, and related naphthazarin natural products. Angewandte. Chemie. International. 38:270-300.
14. Pfaller MA, Jones RN, Doern GV and Kugler K (1998) Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob. Agents. Chemother. 42:1762-1770.
15. Riffel A, Medina LF, Stefani V, Santos RC, Bizani D and Brandelli A (2002) In vitro antimicrobial activity of a new series of 1, 4-naphthoquinones. Braz. J. Med. Biol. Res. 35:811-818.
16. Scheithauer W, Von Hoff DD, Clark GM and Shillis JL, Elslager EF (1986) In vitro activity of the novel antitumor antibiotic fostriecin (CI-920) in a human tumor cloning assay. Eur. J. Cancer. Clin. Oncol. 22:921-926.
17. Tandon VK, Maurya HK, Mishra NN and Shukla PK (2009a) Design, synthesis and biological evaluation of novel nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents. Eur. J. Med. Chem. 44:3130-3137.
18. Tandon VK, Maurya HK, Tripathi A, ShivaKeshava GB, Shukla PK, Srivastava P and Panda D (2009b) 2,3-Disubstituted-1,4-naphthoquinones, 12H-benzo[b] phenothiazine-6,11-diones and related compounds: synthesis and biological evaluation as potential antiproliferative and antifungal agents. Eur. J. Med. Chem. 44:1086-1092.
19. Tewey KM, Chen GL, Nelson EM and Liu LF (1984) Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J. Biol. Chem. 259:9182-9187.
20. Tudor G, Gutierrez P, guilera-Gutierrez A and Sausville EA (2003) Cytotoxicity and apoptosis of benzoquinones: redox cycling, cytochrome c release, and BAD protein expression. Biochem. Pharmacol. 65:1061-1075.